It\u2019s not just that AOD9604 is hard to make (although it is), but also that it\u2019s a very specific modified fragment. It takes no more than a missing disulfide bridge or amino acid to turn AOD9604 into a completely different compound. There\u2019s zero margin for error \u2014 and the quality of your research starts right at the beginning. When you choose where you order AOD9604.<\/p>\n
We\u2019re a scientific and research company based in EU, and our AOD9604 is made to meet your research standards:<\/p>\n
Still got questions? CellPeptides will get them answered, whether they\u2019re about your order or your research design. (No need to ask if we accept crypto, though. We do.)<\/p>\n
Human growth hormone \u2014 which researchers in the fitness or bodybuilding space are already intimately familiar with \u2014 is a serious multi-tasker. It plays parts in processes as diverse as growth, muscle building, metabolism, and tissue healing, and it\u2019s commonly studied for all of those things.<\/p>\n
Sometimes, though, research zooms in on just one area. That\u2019s when AOD9604 comes in handy. This biomimetic was lab-designed to replicate the C-terminal region (amino acids 176-191) of the hGH molecule. That\u2019s the part with the job description of \u201cfat burning.\u201d<\/p>\n
It\u2019s got a two-part mechanism. AOD9604 tells fat cells to break triglycerides into free fatty acids and glycerol \u2014 so they can get used for energy (and disappear). The precise way this works isn\u2019t quite clear yet, but research done to date suggests it happens by switching beta-3 adrenergic receptors on. These attack fat.<\/p>\n
The second part of how AOD9604 works is just as important. While it\u2019s at work attacking existing fat cells, the peptide also sends out signals that prevent more from being formed. This is almost more interesting, because keeping weight off is often just as hard as losing it in the first place.<\/p>\n
Also interesting? Current research shows that AOD9604 is exceptionally safe. It\u2019s a targeted signal that doesn\u2019t touch the parts of growth hormone associated with side effects, and that makes it all the more promising for future studies.<\/p>\n
AOD9604 was explicitly designed with the singular goal of stimulating fat loss in the treatment of obesity. Research into this use case reached the human trial stage, and researchers demonstrated that AOD9604 has an exceptionally good safety profile over the course of these trials.<\/p>\n
Following the science has also led to completely different potential applications for AOD9604, though \u2014 and they\u2019re just as interesting.<\/p>\n
Obesity treatment was the original purpose of AOD9604, something that\u2019s also reflected in its full name \u2014 Anti-Obesity Drug 9604. Research started with animal models, which established its safety to the point that human trials got started, too. Studies done so far (and there are many!) have all found that AOD9604 is a targeted, \u201cclean\u201d growth hormone fragment that triggers lipolysis and prevents new fat cells from growing without having any of the effects of unmodified GH. [1<\/a>, 2<\/a>]\n As for raw power, AOD9608 doesn\u2019t lead to the same impressive weight loss results as, for example, Semaglutide or Tirzepatide \u2014 but it does improve metabolic markers like cholesterol levels.<\/p>\n That gentler action puts AOD9604 into an interesting category, where it doesn\u2019t only have potential as a weight loss peptide for treating overweight and obesity, but also for stubborn fat deposits in non-obese subjects. These fat stores resist exercise and diet \u2014 and eliminating them is of special interest in bodybuilding and other athletic research. [3<\/a>] So far, AOD9604 appears to be especially good at targeting visceral fat (the dangerous kind), because of its action in relation to beta-3 adrenergic receptors. [4<\/a>]\n This is where AOD9604 gets really<\/em> interesting. A peptide designed for fat loss promotes fat loss? More or less \u201cwhat it says on the tin.\u201d But as often happens in peptide research, AOD9604 has turned out to have an entirely different application too \u2014 in joint health.<\/p>\n Numerous animal models have shown that the peptide stimulates cartilage regeneration while pushing inflammation down. Cartilage is, of course, among the slowest tissues to heal, so this application is important. AOD9604 seems to do this by boosting the production of the components needed for cartilage, notably proteoglycans and collagen. [5<\/a>]\n Treatment of osteoarthritis via local injections is one of the most promising potential future clinical applications, but studies have also looked at AOD9604 for osteoporosis treatment \u2014 with equally positive results. [6<\/a>]\n Metabolic and cardiovascular health are closely linked \u2014 and it\u2019s well known that improving the first will also lead to better outcomes in the second area. It\u2019s not at all surprising, then, that some studies have found AOD9604 to be associated with healthier cholesterol and triglyceride profiles. [7<\/a>] There\u2019s also interest in the possibility that the peptide directly improves vascular health, but that\u2019s still an emerging scientific field of inquiry.<\/p>\n The fact that AOD9604 doesn\u2019t bind to growth hormone receptors, and targets a precise pathway related to metabolic health, means it\u2019s most interesting to researchers in the fields of obesity treatment and targeted fat burning, notably visceral fat and body composition improvements.<\/p>\n AOD9604 might be perfect for your lab if you\u2019re researching:<\/p>\n This selective peptide has already been studied in all of these areas, but the most exciting breakthroughs are still waiting for the right science team. Maybe yours?<\/p>\n Dosing in published AOD9604 preclinical and human studies is variable, as it is determined by both the model and the research goals. A review of existing literature is always a good starting point for a new study design, and sufficient research has been done to allow for plenty of insights. Doses often cited range from 200 to 500 mcg (micrograms) administered daily, although some go up to 1000 mcg. Initial doses are lower to allow researchers to observe the model\u2019s initial response. That said, AOD9604 has an exceptional safety profile.<\/p>\n The lyophilized AOD9604 provided by CellPeptides needs to be reconstituted. For use in multi-dose applications, that is done with bacteriostatic water. Lab protocols aren\u2019t optional \u2014 wipe the rubber stoppers of both vials with alcohol wipes, angle the needle at the vial wall, slowly inject BAC water, and then roll or swirl until the solution is clear. AOD9604 will then stay stable between 2 and 8 \u00b0C for multi-dose use, in most cases up to 30-60 days.<\/p>\n To find out the correct dosage for your model – you can use our comprehensive peptide calculator here<\/a>.<\/p>\n How long can researchers expect to wait before they can observe results with AOD9604?<\/strong><\/p>\n That time frame depends on both the model and the goal \u2014 because fat loss and cartilage regeneration are not the same. The research design also impacts it. Data should generally be collected over a period of at least several weeks before it becomes possible to adequately measure the response.<\/p>\n Can AOD9604 cause<\/em> weight gain?<\/strong><\/p>\n The opposite effect \u2014 fat and weight loss \u2014 is at once the main purpose of AOD9604 and its observed effect in research. Some growth hormone peptides are researched for weight gain (\u201cbulking\u201d), but AOD9604 is a fragment that eliminates this effect.<\/p>\n How does AOD9604 compare to hGH?<\/strong><\/p>\n The full and natural hormone binds to the growth hormone receptor, where it produces a range of effects. AOD9604 is a fragment that solely isolates effects related to fat metabolism.<\/p>\n What is the observed effect of AOD9604 on belly fat?<\/strong><\/p>\n Studies that have looked at abdominal fat stores have found a reduction in waist circumference. AOD9604 is designed to fight all fat stores, including belly fat.<\/p>\n Pro\u010d vytv\u00e1\u0159et novou molekulu od z\u00e1kladu, kdy\u017e m\u016f\u017eete upravit ji\u017e existuj\u00edc\u00ed tak, aby selektivn\u011b \u201cod\u0161t\u00edpla\u201d pouze tu, kterou chcete? Klinick\u00e9 studie na lidech, kter\u00e9 zkoumaly jeho schopnost spalovat tuk, v\u0161ak brzy vedly k objevu mnohem \u0161ir\u0161\u00edch mo\u017enost\u00ed vyu\u017eit\u00ed. Ukazuje se toti\u017e, \u017ee AOD9604 je zaj\u00edmav\u00fd mnohem v\u00edc ne\u017e jen pro c\u00edlen\u00e9 hubnut\u00ed. Nov\u011bj\u0161\u00ed v\u00fdzkum tohoto modifikovan\u00e9ho fragmentu r\u016fstov\u00e9ho hormonu se zab\u00fdval l\u00e1tkou AOD9604 jako slibnou l\u00e9\u010dbou osteoartr\u00f3zy \u2013 a to kv\u016fli jej\u00edmu zjevn\u00e9mu potenci\u00e1lu pro lok\u00e1ln\u00ed obnovu chrupavek. Dal\u0161\u00ed v\u00fdzkumn\u00e9 sm\u011bry? \u00daleva od bolesti, regenerace tk\u00e1n\u00ed nad r\u00e1mec chrupavek a aplikace pro zdrav\u00ed srdce.<\/p>\n AOD9604 je peptid s v\u00edce mechanismy \u00fa\u010dinku pro v\u00fdzkumn\u00edky, kte\u0159\u00ed se zaj\u00edmaj\u00ed o souvislosti mezi metabolismem, tukem a hojen\u00edm tk\u00e1n\u00ed. C\u00edle studi\u00ed se r\u016fzn\u00ed, ale pot\u0159eba \u010dist\u00e9ho, pe\u010dliv\u011b syntetizovan\u00e9ho AOD9604 je spole\u010dn\u00e1 v\u0161em v\u00fdzkumn\u00edk\u016fm. Zahajte sv\u016fj v\u00fdzkum s farmaceuticky \u010dist\u00fdm AOD9604 od spole\u010dnosti CellPeptides.<\/p>","protected":false},"featured_media":983,"template":"","meta":{"_acf_changed":false,"ub_ctt_via":""},"product_brand":[],"product_cat":[45,54,51],"product_tag":[],"class_list":["post-818","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides-for-fat-metabolism-research","product_cat-peptides-for-tissue-healing-research","product_cat-peptides-for-weight-management-research","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"yoast_head":"\nTargeted Fat Burning (Beyond Obesity)<\/h3>\n
AOD9604 for Osteoarthritis and Joint Health<\/h3>\n
Cardiovascular Health Improvements Seen with AOD9604<\/h3>\n
Who Might Consider Researching AOD9604?<\/h2>\n
\n
Common Dosing Protocols for AOD9604 In Research In-Vitro Setting<\/h2>\n
FAQs<\/h2>\n
Scientific References<\/em><\/h2>\n
\n
\nTo bylo jednoduch\u00e9 v\u00fdchodisko za AOD9604 \u2014 modifikace r\u016fstov\u00e9ho hormonu na \u010dist\u00fd sign\u00e1l spaluj\u00edc\u00ed tuk<\/strong>. Takov\u00fd, kter\u00fd vynech\u00e1v\u00e1 r\u016fstov\u00e9 \u00fa\u010dinky, kter\u00fdmi je r\u016fstov\u00fd hormon proslul\u00fd, spolu se zadr\u017eov\u00e1n\u00edm vody a inzulinovou rezistenc\u00ed, kter\u00e9 mohou b\u00fdt ne\u017e\u00e1douc\u00edm bonusem.<\/p>\n